Healthcare -
Biotechnology - NASDAQ - US
$ 6.39
-5.11 %
$ 42.1 M
Market Cap
-0.52
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
Forte Biosciences, Inc.
| Revenue | 0 |
| Cost Of Revenue | 0 |
| Gross Profit | 0 |
| Operating Expenses | 36.6 M |
| Operating Income | -36.6 M |
| Other Expenses | -1.12 M |
| Net Income | -35.5 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 18.0 | 41 K | 49 K | 51 K |
| GROSS PROFIT | ||||||||||
| Cost Of Revenue | 0 | 9 K | 0 | 36 K | 54 K | 11 K | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 9 K | 0 | 36 K | 54 K | 11 K | 18.0 | 41 K | 49 K | 51 K |
| OPERATING INCOME | ||||||||||
| Operating Expenses | 36.6 | 32.5 | 13.9 | 21.5 | 14.2 | 4.1 | 63.3 | 37.4 | 31.5 | 22.8 |
| Selling, General and Administrative Expenses | 15.4 | 10.6 | 8.3 | 7.6 | 4.2 | 1.4 | 12.8 | 8.3 | 4.3 | 3.6 |
| Research and Development Expenses | 20.7 | 21.9 | 5.6 | 13.9 | 10.0 | 2.7 | 50.5 | 29.1 | 27.2 | 19.2 |
| Operating Income | (36.6) | (32.5) | (13.9) | (21.5) | 17.8 | (4.1) | (45.9) | (37.6) | (31.7) | (23.0) |
| PRE-TAX INCOME | ||||||||||
| Interest Income Expense | 0 | 0 | 0 | 0 | 0 | -- | 0.2 | 1.9 | (1.8) | (0.1) |
| Total Other Income | 1.1 | 1.0 | 17 K | (0.2) | (0.2) | 5 K | (1.4) | (1.3) | (1.8) | (0.1) |
| Pre-Tax Income | (35.5) | (31.5) | (13.9) | (21.7) | (46.5) | (4.1) | (47.3) | (38.9) | (33.5) | (23.1) |
| NET INCOME | ||||||||||
| Tax Provision | 0 | 0 | 17 K | (0.2) | 32.1 | 2.52 K | 1.7 | (2.6) | (3.7) | (0.2) |
| Net Income | (35.5) | (31.5) | (13.9) | (21.7) | (78.5) | (4.1) | (49.0) | (38.9) | (33.5) | (23.1) |
| EPS | 12.2 | 24.9 | 20 | 38.9 | 158 | 48.3 | 915 | 998 | 635 | 474 |